Keywords: بازدارنده های نوع 5 فسفودی استراز; Association; Meta-Analysis; Non-Arteritic Anterior Ischemic Optic Neuropathy; Phosphodiesterase Type 5 Inhibitors; Systematic Review;
مقالات ISI بازدارنده های نوع 5 فسفودی استراز (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: بازدارنده های نوع 5 فسفودی استراز; Phosphodiesterase Type 5 Inhibitors; Erectile Dysfunction; Safety; Melanoma; Prostate Cancer;
Keywords: بازدارنده های نوع 5 فسفودی استراز; ED; erectile dysfunction; IIEF-5; five-item version of the International Index of Erectile Function; PDE5i; phosphodiesterase type 5 inhibitors; S-EM; sex-enhancing medications; Characteristics; Phosphodiesterase type 5 inhibitors; Sex-enhancing medicatio
Keywords: بازدارنده های نوع 5 فسفودی استراز; Sexual health; Premature ejaculation; Phosphodiesterase type 5 inhibitors;
Keywords: بازدارنده های نوع 5 فسفودی استراز; Phosphodiesterase Type 5 Inhibitors; Sildenafil; Tadalafil; Vardenafil; Avanafil;
Keywords: بازدارنده های نوع 5 فسفودی استراز; PDE5; phosphodiesterase type 5; BDNF; brain derived neurotrophic factor; NE; norepinephrine; 5-HIAA; 5-hydroxyindoleacetic acid; ROS; reactive oxygen species; Noise; Sildenafil; Phosphodiesterase type 5 inhibitors; Oxidative stress; Cognition; Behavior; M
Keywords: بازدارنده های نوع 5 فسفودی استراز; Coronary artery disease; Cardiovascular mortality; Cardiovascular events; Phosphodiesterase type 5 inhibitors; Erectile dysfunction;
Keywords: بازدارنده های نوع 5 فسفودی استراز; Meta-analysis; Pulmonary arterial hypertension; Endothelin receptor antagonists; Phosphodiesterase type 5 inhibitors; Prostanoids; Soluble guanylate cyclase stimulators; Prostacyclin;
Keywords: بازدارنده های نوع 5 فسفودی استراز; AE, adverse event; ED, erectile dysfunction; IIEF-5, five-item version of the International Index of Erectile Function questionnaire; PDE5i, phosphodiesterase type 5 inhibitorsIrrational; Men; Erectile dysfunction; Phosphodiesterase type 5 inhibitors
Keywords: بازدارنده های نوع 5 فسفودی استراز; Erectile Dysfunction; Phosphodiesterase Type 5 Inhibitors; Udenafil; Long Term
Keywords: بازدارنده های نوع 5 فسفودی استراز; Basal cell carcinoma; Erectile dysfunction; Melanoma skin cancer; Phosphodiesterase type 5 inhibitors; Squamous cell carcinoma;
Keywords: بازدارنده های نوع 5 فسفودی استراز; Pulmonary hypertension; Pulmonary arterial hypertension; Review; Endothelin receptor antagonist; Phosphodiesterase type 5 inhibitors; Prostacyclin analogs; Hipertensión pulmonar; Hipertensión arterial pulmonar; Revisión; Antagonista del receptor de end
Keywords: بازدارنده های نوع 5 فسفودی استراز; Erectile Dysfunction; Benign Prostatic Hyperplasia; Phosphodiesterase Type 5 Inhibitors; Tadalafil; Testosterone; Luteinizing Hormone;
Keywords: بازدارنده های نوع 5 فسفودی استراز; Hipertensión pulmonar; Hipertensión arterial pulmonar; Revisión; Antagonista del receptor de endotelina; Inhibidores de la fosfodiesterasa tipo 5; Análagos de prostaciclina; Pulmonary hypertension; Pulmonary arterial hypertension; Review; Endothelin r
Keywords: بازدارنده های نوع 5 فسفودی استراز; Phosphodiesterase type 5 inhibitors; Lower urinary tract symptoms; Benign prostatic enlargement; Benign prostatic hyperplasia; Erectile dysfunction; Sildenafil; Vardenafil; Tadalafil; Avanafil; Prostate;
Keywords: بازدارنده های نوع 5 فسفودی استراز; age; outcomes; pulmonary arterial hypertension; pulmonary hypertension; 6MWD; 6-min walk distance; COMPERA; Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension; CTD; connective tissue disease; ERA; endothelin receptor
Keywords: بازدارنده های نوع 5 فسفودی استراز; Erectile Dysfunction; Phosphodiesterase Type 5 Inhibitors; Tadalafil; Data Pooling; Treatment Efficacy;
Keywords: بازدارنده های نوع 5 فسفودی استراز; Prostate cancer; Radical prostatectomy; Phosphodiesterase type 5 inhibitors; Biochemical recurrence;
Keywords: بازدارنده های نوع 5 فسفودی استراز; Lower urinary tract symptoms (LUTS); Overactive bladder syndrome (OAB); Phosphodiesterase type 5 inhibitors; NO/cGMP; cAMP
Keywords: بازدارنده های نوع 5 فسفودی استراز; 5‐Alpha Reductase Inhibitors; Benign Prostatic Hyperplasia; Ejaculatory Function; Erectile Dysfunction; Finasteride; Lower Urinary Tract Symptoms; Orgasmic Function; Phosphodiesterase Type 5 Inhibitors; Tadalafil
Keywords: بازدارنده های نوع 5 فسفودی استراز; Erectile dysfunction drugs; Flavonoids; Phosphodiesterase type 5 inhibitors; Premature ejaculation; Counterfeit samples; Adulterated dietary supplements.
Keywords: بازدارنده های نوع 5 فسفودی استراز; Drug Prescriptions; Erectile Dysfunction; Radical Prostatectomy; Radiotherapy; Phosphodiesterase Type 5 Inhibitors; Prostate Cancer; Sweden
Keywords: بازدارنده های نوع 5 فسفودی استراز; Erectile dysfunction; Coronary artery disease; Cardiovascular diseases; Artery-size hypothesis; Screening; Phosphodiesterase type 5 inhibitors
Calidad de la vida sexual de varones heterosexuales con lesión medular en tratamiento farmacológico para la disfunción eréctil y de sus compañeras
Keywords: بازدارنده های نوع 5 فسفودی استراز; Lesión medular; Disfunción sexual; Inhibidores de fosfodiesterasa 5; Calidad de vida sexual; Cuestionario SLQQ; Parejas; Spinal cord injury; Sexual dysfunction; Phosphodiesterase type 5 inhibitors; Sexual life quality; SLQQ questionnaire; Couples;
Erectile Dysfunction: AUA Guideline
Keywords: بازدارنده های نوع 5 فسفودی استراز; physiological sexual dysfunction; men's health; cardiovascular diseases; clinical decision/making; psychological sexual dysfunction; AEs; adverse events; AUA; American Urological Association; ED; erectile dysfunction; EF; erectile function; ICI; intracave
Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims Database
Keywords: بازدارنده های نوع 5 فسفودی استراز; Bladder Cancer; Cystectomy; Erectile Dysfunction; Phosphodiesterase Type 5 Inhibitors; Pharmacotherapy; Quality Of Life;
Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME)
Keywords: بازدارنده های نوع 5 فسفودی استراز; Testosterone Replacement Therapy; Hypogonadism; Sexual Function; Quality of Life; Phosphodiesterase Type 5 Inhibitors;
Sexual Rehabilitation After Treatment For Prostate Cancer-Part 2: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015)
Keywords: بازدارنده های نوع 5 فسفودی استراز; Prostate Cancer; Radical Prostatectomy; Erectile Dysfunction; Rehabilitation; Phosphodiesterase Type 5 Inhibitors; Alprostadil; Intracavernosal Injections; Sexual Desire; Orgasm; Climacturia; Peyronie Disease;
Adulteration of synthetic PDE-5 inhibitors viz., sildenafil and tadalafil in marketed herbal aphrodisiacs
Keywords: بازدارنده های نوع 5 فسفودی استراز; High performance liquid chromatography (HPLC); Phosphodiesterase type 5 inhibitors; Aphrodisiacs; Sildenafil; Tadalafil;
Exploratory Decision-Tree Modeling of Data from the Randomized REACTT Trial of Tadalafil Versus Placebo to Predict Recovery of Erectile Function After Bilateral Nerve-Sparing Radical Prostatectomy
Keywords: بازدارنده های نوع 5 فسفودی استراز; Clinical trials; Decision-tree analysis; Erectile dysfunction; Nerve-sparing radical prostatectomy; Phosphodiesterase type 5 inhibitors; Predictors; Prostate cancer; Rehabilitation; Tadalafil;
Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015)
Keywords: بازدارنده های نوع 5 فسفودی استراز; Erectile Dysfunction; Pharmacotherapy; Phosphodiesterase Type 5 Inhibitors
2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. Summary document prepared by the Czech Society of Cardiology
Keywords: بازدارنده های نوع 5 فسفودی استراز; Guidelines; Pulmonary hypertension; Pulmonary arterial hypertension; Chronic thromboembolic pulmonary hypertension; Congenital heart disease; Connective tissue disease; Heart failure; Respiratory failure; Endothelin receptor antagonists; Phosphodiesterase
Efficacy of testosterone combined with a PDE5 inhibitor and testosterone combined with a serotonin 1A receptor agonist in women with SSRI-induced sexual dysfunction. A preliminary study
Keywords: بازدارنده های نوع 5 فسفودی استراز; SSRI-induced sexual dysfunction; Sublingual testosterone; Phosphodiesterase type 5 inhibitors; Serotonin; Serotonin 1A receptor agonist; CAG repeat length;
Antenatal maternally-administered phosphodiesterase type 5 inhibitors normalize eNOS expression in the fetal lamb model of congenital diaphragmatic hernia
Keywords: بازدارنده های نوع 5 فسفودی استراز; Congenital diaphragmatic hernia; DH; Pulmonary hypertension; Phosphodiesterase type 5 inhibitors; PDE5 inhibitors
Effects of Tadalafil Treatment on Erectile Function Recovery Following Bilateral Nerve-sparing Radical Prostatectomy: A Randomised Placebo-controlled Study (REACTT)
Keywords: بازدارنده های نوع 5 فسفودی استراز; Clinical trials; Erectile dysfunction; Nerve-sparing prostatectomy; Penile function; Phosphodiesterase type 5 inhibitors; Prostate cancer; Radical prostatectomy; Rehabilitation; Tadalafil once a day;
Tadalafil Once Daily in Men with Erectile Dysfunction: An Integrated Analysis of Data Obtained from 1913 Patients from Six Randomized, Double-blind, Placebo-controlled, Clinical Studies
Keywords: بازدارنده های نوع 5 فسفودی استراز; Comorbidities; Diabetes; Erectile dysfunction; Metabolic syndrome; Once daily; Phosphodiesterase type 5 inhibitors; Tadalafil
Duration of Erection: Does It Really Matter? A Randomized, DoubleâBlind Clinical Trial to Assess the Impact of Vardenafil ODT on Duration of Erection and Its Correlation with Patients' and Partners' Sexual Quality of Life and Duration of Intercourse: Th
Keywords: بازدارنده های نوع 5 فسفودی استراز; Erectile Dysfunction; Duration of Erection; Phosphodiesterase Type 5 Inhibitors; Vardenafil; IIEF; SEPâ3; Orodispersible Tablet;
Sequential, non-arteritic anterior ischemic optic neuropathy in patients taking sildenafil: a report of ten cases
Keywords: بازدارنده های نوع 5 فسفودی استراز; Non-arteritic anterior ischemic optic neuropathy; Sildenafil; Phosphodiesterase type 5 inhibitors
Adulteration of Purported Herbal and Natural Sexual Performance Enhancement Dietary Supplements with Synthetic Phosphodiesterase Type 5 Inhibitors
Keywords: بازدارنده های نوع 5 فسفودی استراز; Erectile Dysfunction; Herbal Medicine; Phosphodiesterase Type 5 Inhibitors; Sildenafil
Tadalafil Once Daily Improves Ejaculatory Function, Erectile Function, and Sexual Satisfaction in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia and Erectile Dysfunction: Results from a Randomized, Placebo‐ and Tamsulosin
Keywords: بازدارنده های نوع 5 فسفودی استراز; Erectile Dysfunction; Phosphodiesterase Type 5 Inhibitors; Ejaculation; Orgasm; Ejaculatory Dysfunction; Sexual Function; Alpha Adrenergic Blockers; Benign Prostatic Hyperplasia; Lower Urinary Tract Symptoms
The Role of Initial Success Rates and Other Factors in Determining Reliability of Outcomes of Phosphodiesterase Inhibitor Therapy for Erectile Dysfunction: A Pooled Analysis of 17 PlaceboâControlled Trials of Tadalafil for Use as Needed
Keywords: بازدارنده های نوع 5 فسفودی استراز; Erectile Dysfunction; Phosphodiesterase Type 5 Inhibitors; PDE5; Tadalafil; Reliability of Efficacy; Pooled Analysis;
The Mechanism of Action of Phosphodiesterase Type 5 Inhibitors in the Treatment of Lower Urinary Tract Symptoms Related to Benign Prostatic Hyperplasia
Keywords: بازدارنده های نوع 5 فسفودی استراز; Benign prostatic hyperplasia; Lower urinary tract symptoms; Phosphodiesterase type 5; Phosphodiesterase type 5 inhibitors; Mechanism of action
Comparative Effectiveness and Safety of Oral Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction: A Systematic Review and Network Meta-analysis
Keywords: بازدارنده های نوع 5 فسفودی استراز; Phosphodiesterase type 5 inhibitors; Erectile dysfunction; Systematic review; Network meta-analysis
Delay in Seeking Medical Help in Patients with NewâOnset Erectile Dysfunction Remained High Over and Despite the PDE5 Era-An Ecological Study
Keywords: بازدارنده های نوع 5 فسفودی استراز; Erectile Dysfunction; Awareness; Phosphodiesterase Type 5 Inhibitors; Sildenafil; Tadalafil; Vardenafil;
Couples' Reasons for Adherence to, or Discontinuation of, PDE Type 5 Inhibitors for Men with Erectile Dysfunction at 12 to 24‐Month Follow‐Up after a 6‐Month Free Trial
Keywords: بازدارنده های نوع 5 فسفودی استراز; Adherence; Discontinuation; Phosphodiesterase Type 5 Inhibitors; Erectile Dysfunction; Couples; Sildenafil; Tadalafil; Vardenafil
Monotherapy with Tadalafil or Tamsulosin Similarly Improved Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia in an International, Randomised, Parallel, Placebo-Controlled Clinical Trial
Keywords: بازدارنده های نوع 5 فسفودی استراز; Benign prostatic hyperplasia; Erectile dysfunction; Lower urinary tract symptoms; Phosphodiesterase type 5 inhibitors; Tadalafil; Tamsulosin
Choosing the Best Candidates for Penile Rehabilitation after Bilateral Nerve‐Sparing Radical Prostatectomy
Keywords: بازدارنده های نوع 5 فسفودی استراز; Erectile Dysfunction; Radical Prostatectomy; Rehabilitation; Phosphodiesterase Type 5 Inhibitors
Tadalafil 2.5 or 5 mg Administered Once Daily for 12 Weeks in Men with Both Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia: Results of a Randomized, Placebo‐Controlled, Double‐Blind Study
Keywords: بازدارنده های نوع 5 فسفودی استراز; Benign Prostatic Hyperplasia; Phosphodiesterase Type 5 Inhibitors; Tadalafil
Does Current Scientific and Clinical Evidence Support the Use of Phosphodiesterase Type 5 Inhibitors for the Treatment of Premature Ejaculation? A Systematic Review and Metaâanalysis
Keywords: بازدارنده های نوع 5 فسفودی استراز; Premature Ejaculation; Phosphodiesterase Type 5 Inhibitors; Pharmacologic Therapy of Premature Ejaculation; Sildenafil; Tadalafil; Vardenafil;
Tadalafil Enhances the Inhibitory Effects of Tamsulosin on Neurogenic Contractions of Human Prostate and Bladder Neck
Keywords: بازدارنده های نوع 5 فسفودی استراز; Benign Prostatic Hyperplasia; Erectile Dysfunction; Lower Urinary Tract Symptoms; Phosphodiesterase Type 5 Inhibitors; Tadalafil; Tamsulosin